EGFR Inhibitor-Associated Skin Rash Targeted (Proactive Acne Treatment) by Hana Biosciences

Genetic Engineering News - The company reports that an estimated 75% of cancer patients receiving treatment with EGFR inhibitors develop significant skin toxicities presenting as acne-like rash on the face and upper body. Menadione, a small molecule phosphatase inhibitor, is More

Tags: , , ,

Comments are closed.